Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

@article{Chouinard2017AntipsychoticInducedDS,
  title={Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy},
  author={G. Chouinard and Anne-No{\"e}l Samaha and V. Chouinard and Charles-Siegfried Peretti and N. Kanahara and Masayuki Takase and M. Iyo},
  journal={Psychotherapy and Psychosomatics},
  year={2017},
  volume={86},
  pages={189 - 219}
}
  • G. Chouinard, Anne-Noël Samaha, +4 authors M. Iyo
  • Published 2017
  • Medicine
  • Psychotherapy and Psychosomatics
  • The first-line treatment for psychotic disorders remains antipsychotic drugs with receptor antagonist properties at D2-like dopamine receptors. However, long-term administration of antipsychotics can upregulate D2 receptors and produce receptor supersensitivity manifested by behavioral supersensitivity to dopamine stimulation in animals, and movement disorders and supersensitivity psychosis (SP) in patients. Antipsychotic-induced SP was first described as the emergence of psychotic symptoms… CONTINUE READING
    73 Citations
    Antipsychotic-evoked dopamine supersensitivity
    • 4
    Dopamine D2 up-regulation in psychosis patients after antipsychotic drug treatment.
    • 1
    • PDF
    Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice
    • 12
    The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
    • 14
    • PDF

    References

    SHOWING 1-10 OF 238 REFERENCES
    Dopamine D2 receptors as treatment targets in schizophrenia.
    • P. Seeman
    • Medicine
    • Clinical schizophrenia & related psychoses
    • 2010
    • 148
    Can antipsychotic treatment contribute to drug addiction in schizophrenia?
    • Anne-Noël Samaha
    • Psychology, Medicine
    • Progress in Neuro-Psychopharmacology and Biological Psychiatry
    • 2014
    • 37
    • PDF